AIDS 2024, the 25th International AIDS Conference

July 22–26, 2024

Munich, Germany

Event Website

AIDS 2024 will convene thousands of people living with, affected by and working on HIV to share knowledge, best practices and lessons learnt from the HIV response over the past 40 years, as well as from the responses to COVID-19, mpox, and other public health threats.

 

Population Council staff will be co-hosting a satellite, speaking at a symposium, facilitating a workshop, and presenting several posters. Council staff attending include Barbara Friedland, Ann Gottert, Sinazo Pato, Diantha Pillay, Julie Pulerwitz, Niranjan Saggurti, Jim Sailer, and Leonard Solai.

 

In the list of activities below Population Council staff are in bold; An asterisk (*) denotes presenter

Sessions & Speakers

  1. Tuesday 07/23

      E-Poster | 10:00 CEST | Online

      Perspectives of cisgender women, transgender men, and healthcare providers on an HIV risk self-assessment digital chatbot (Abstract)

      S. Mathur*, W. Tun, A. Eromhonsele, Z. Vallarino, O. Ononye, C. Savel, M. Akoro, E. Oche, A. Adedimeji, E. Shoyemi

       

        Poster Exhbition | 12:00–13:00 CEST | Exhibition Hall

        (Posters are on display all day, but presenters stand by their posters during this time)

         

        TUPEC192

        Acceptability of a dual prevention pill versus PrEP and oral contraceptives taken separately: women’s baseline preferences in Johannesburg, South Africa (Abstract)

        J.B. Burnett-Zieman, T. Palanee-Philips, M. Plagianos, S. Mathur, S. Zulu, K. Reddy, I. Bruce, N. Ndlovu, L. Haddad, B. Friedland*

         

        TUPED341

        The impact of multilevel interventions on alcohol consumption, depression, stigma, and ART adherence among men living with HIV in India: Results from a 27-month longitudinal study (Abstract)

        T. Ha*, S. Schensul, R. Singh, L. Frank

      • Wednesday 07/24

          Workshop | 10:00–11:30 CEST | Room 14a/Channel 9

          WS07

          Two for the price of one: Simplifying access to HIV prevention and contraception with multipurpose prevention technologies (Abstract)

          Facilitators: Danielle Resar, Wawira Nyagah, Lori Miller, Barbara Friedland

           

          The dual prevention pill (DPP), which combines oral PrEP and oral contraception, could be the next multipurpose prevention technology (MPT) available, with expected approval in 2025. However, successful rollout of MPTs is highly dependent on integration of HIV and sexual and reproductive health (SRH) services and programmes, which has been challenging to realize. This workshop will leverage the expertise of HIV and SRH stakeholders to examine strategies for successfully introducing the DPP and use it as a model for delivering future MPTs. Discussions will focus on financing, regulatory, procurement and service delivery priorities for accelerating rollout and access to the DPP and other MPTs.

            Poster Exhibition | 12:00–13:00 CEST | Exhibition Hall

            (Posters are on display all day, but presenters stand by their posters during this time)

             

            WEPEC226

            Size matters: a randomized controlled trial to assess the impact of external diameter on preference, adherence, and acceptability of three intravaginal rings (IVRs) in 24 US couples (Abstract)

            B.A. Friedland*, M. Plagianos, I. Bruce, J. Sales, J. Atrio, A. Gottert, S. Shetty, C. Sant’Anna Marinho, J.B. Burnett-Zieman, R. Merkatz, L.B. Haddad

             

            WEPEC231

            The intravaginal ring acceptability scale (IVR-AS): A new tool to improve and standardize vaginal ring acceptability measurement among end-users (Abstract)

            A. Gottert*, B.A. Friedland, M. Plagianos, B. Zieman, J.M. Sales, J. Atrio, S. Shetty, C. Sant’Anna Marinho, R. Merkatz, L.B. Haddad

             

            WEPED428

            HIV-related discussions with sex partners by Nigerian transgender women and men who have sex with men (Abstract)

            A.B. Tiamiyu*, F. Hu, A. Kokogho, M.E. Charurat, C. Ekeh, S. Adebajo, E. Shoyemi, M. Iroezindu, J.A. Ake, S.D. Baral, R. Nowak, T.A. Crowell, TRUST/RV368 Study Group

              Symposium | 16:30–17:30 CEST | Room 1/Channel 2

              SY20

              The impact on access to HIV prevention and treatment services of migration and displacement among people in Southeast Asia (Abstract)

              Niranjan Saggurti (Speaker)

               

              Mobility and displacement are linked to reduced access to and poorer outcomes of HIV care due to several reasons. Mobile populations have unique vulnerabilities that may impact timeliness of clinic visits; location may also impact ability to access healthcare services. There may be specific challenges faced by some groups, including women and trans populations, in some parts of the world. This session will focus on the challenges to access to HIV prevention and care services introduced by migration, mobility and displacement across several locations and key populations globally.

            • Thursday 07/25

                Satellite | 07:00–08:00 CEST | Room 5/Channel 8

                SAT094

                HIV prevention for women: What’s in the current toolkit and where do we go from here? (Abstract)

                Co-organizers: Population Council and African Women Prevention Community Accountability Board

                 

                The HIV epidemic is entering its fifth decade. Despite the availability of treatment and new prevention options, HIV/AIDS remains the leading cause of death in sub-Saharan Africa. To end this epidemic, women and girls need access to a variety of prevention products that align with their preferences. Currently available biomedical prevention options include oral PrEP, the monthly dapivirine ring (DVR), and the recently approved cabotegravir injectable. Developers are working on expanding this toolkit with improvements on longer-acting injectables and rings as well as on-demand products such as inserts. However, the promise of biomedical HIV prevention products will only be realized if women can obtain products easily and affordably and if they are empowered to use these products. Product choice empowers women to select and use products which fit their unique lifestyle and circumstances. This satellite session will be co-hosted by Population Council and African Women’s HIV Prevention Accountability Board (AWPCAB) and will serve as a platform to discuss what is needed to make the current options available for all women and how to balance resources for expanding access to existing methods while simultaneously developing new methods. We will convene an expert panel to discuss strategies for overcoming the barriers to expanding access to the existing methods, as well as the trade-offs investing in scaling up currently available methods versus developing new methods. Experts may include a product developer, an implementing partner, an HIV prevention advocate, and a civil society representative. The panel will be moderated by an expert with input from the audience in the form of Q&A.

                  Poster Exhibition | 12:00–13:00 CEST | Exhibition Hall

                  (Posters are on display all day, but presenters stand by their posters during this time)

                   

                  THPEC203

                  A dual prevention pill for HIV and pregnancy prevention: Results from a pilot study among Adolescent girls and young women in Zimbabwe (Abstract)

                  B.A Friedland*, M. Plagianos, JB. Burnett-Zieman, S. Mathur, I. Bruce, A. Dandadzi, P. Musara, C. Murombedzi, L.B Haddad, N.M. Mgodi

                   

                  THPED425

                  Stigma reduction and mental health promotion for sexual and gender minorities at risk of/living with HIV in Nigeria: implementation lessons (Abstract)

                  A. Fernandez Eromhonsele, J. Pulerwitz, W. Tun, A. Gottert*, A. Adedimeji

                   

                   

                Go to Top